2017 Prostate Cancer Academy

Dear LUGPA Member,

In our shared goal to ensure that LUGPA members receive optimal education on prostate cancer diagnosis and management, advanced monitoring and care options, novel pharmaceutical therapies, and surgical advancements, we pleased to announce the 2017 Prostate Cancer Academy (PCA) program. PCA is co-sponsored by MedReviews, LLC, publishers of Reviews in Urology®, and LUGPA.

PCA 2016 was highly successful, with more than 90 residents, fellows, and LUGPA members in attendance. Our outstanding faculty presented robust talks on the most relevant topics in our field, and we are looking forward to an even better program in 2017.

Prostate Cancer Academy will convene the evening of Thursday, October 12, and continue through mid-day on Saturday, October 14, in Los Angeles, California. The program will present, discuss, and debate all available preventative, diagnostic, therapeutic, and management options for prostate cancer in a highly interactive format. PCA will include didactic lectures, case-based discussions, and faculty panels.

This program is presented at no cost to you. PCA will cover round-trip air travel, two nights’ lodging, and onsite meals for the duration of the program.

Fifty PCA slots are available to LUGPA members, on a first-come, first-served basis. Preference will be given to those who have not previously attended PCA. To register for the meeting, please visit: www.prostateacademy.com and click on Attendee Registration. Please register as soon as possible, as space is limited.

Please review the enclosed course agenda. If you have questions or require additional information, contact Danielle Wagner, Associate Director of Program Management with MedReviews, via e-mail at dwagner@medreviews.com.

Thank you in advance for your immediate attention, time, and support.

Sincerely,

Herbert Lepor, MD
Professor, Department of Urology
Martin Spatz Chair, Department of Urology
Professor, Department of Biochemistry and
Molecular Pharmacology
NYU Langone Medical Center
New York, NY

Neal D. Shore, MD, FACS
President, LUGPA
Medical Director, Certified Physician Investigator
Carolina Urologic Research Center
Atlantic Urology Clinics
Myrtle Beach, SC


Prostate Cancer Academy 2017 Agenda*

Thursday, October 12th
6:00 pm – 8:30 pm
Registration Desk Open
6:30 pm – 8:30 pm
Welcome Reception
Friday, October 13th
Topic
Speaker
7:45 am
Welcome & Introduction
Herbert Lepor, MD
NYU Langone Medical Center
8:00 am – 8:50 am
Breakfast
8:55 am
Castration-resistant Prostate Cancer: Infusion Therapeutics
Charles J. Ryan, MD
UCSF Helen Diller Family Comprehensive Cancer Center
9:35 am
Castration-resistant Prostate Cancer: Oral Therapeutics
Charles J. Ryan, MD
UCSF Helen Diller Family Comprehensive Cancer Center
10:15 am – 10:40 am
Morning Break
10:45 am
Improving Specificity of PSA Screening: Serum and Urine Markers – Who Doesn’t Need a Prostate Biopsy?
Daniel W. Lin, MD
University of Washington
11:25 am
Risk Stratifying Low Risk Disease: Molecular Markers
Daniel W. Lin, MD
University of Washington
12:05 pm
The Role of MRI in Prostate Biopsy: Who and How to Biopsy?
Samir Taneja, MD
NYU Langone Medical Center
12:45 pm – 1:45 pm
Lunch
1:50 pm
Treatment of Locally Advanced Prostate Cancer
Christopher J. Kane, MD
UC San Diego Health
2:30 pm
Advances in PET Imaging
Phillip J. Koo, MD
Banner MD Anderson Cancer Center
3:10 pm
Managing Bone Health in Advanced Prostate Cancer: What Every Urologist Should Know
Stephen Freedland, MD
Cedars-Sinai Medical Center
3:50 pm – 4:15 pm
Afternoon Break
4:20 pm
New Payment Models for Healthcare
Alec S. Koo, MD, FACS
Skyline Urology
5:00 pm
Case Presentation with Panel Discussion
Herbert Lepor, MD
NYU Langone Medical Center
5:30 pm
Wrap-up Session
5:45 pm – 6:45 pm
Networking Reception
6:45 pm – 7:45 pm
Dinner
Saturday, October 14th
Topic
Speaker
7:00 am
Opening Remarks: Advanced Prostate Cancer: Is There a Role for Urologists?
Neal D. Shore, MD, FACS
Carolina Urologic Research Center
Atlantic Urology Clinics
7:10 am – 8:00 am
Breakfast
8:05 am
Future of Urology / Role of LUGPA
Neal D. Shore, MD, FACS
Carolina Urologic Research Center
Atlantic Urology Clinics
8:45 am
IMRT/Proton Beam/Cyberknife: Pros and Cons
Steven E. Finkelstein, MD
Cancer Treatment Centers of America
9:25 am
Ablation of Prostate Cancer: Is It Ready for Prime Time?
Herbert Lepor, MD
NYU Langone Medical Center
10:05 am – 10:30 am
Morning Break
10:35 am
LHRH Antagonists vs Agonists
E. David Crawford, MD
University of Colorado, Anschutz Medical Campus
11:15 am
Panel Discussion
Neal D. Shore, MD, FACS
Carolina Urologic Research Center
Atlantic Urology Clinics
11:50 am
Closing Remarks
Neal D. Shore, MD, FACS
Carolina Urologic Research Center
Atlantic Urology Clinics
12:00 pm
Departures

 

*Topics and speakers subject to change.